Point-of-care diagnostics for tuberculosis elimination? – In this commentary published in The Lancet, Christian Wejse cites a recent randomized trial comparing point-of-care GeneXpert with smear microscopy in the management of TB to argue that instead of investing heavily to provide all peripheral health facilities in the world with GeneXpert, the same investment could ensure that […]
HIV
The goals of controlling HIV sound like a straight forward series of three consecutive steps, one following another, when discussed in global and domestic epidemic-ending plans. […]
Tuberculosis
The announcement Wednesday of U.S. Food and Drug Administration approval of pretomanid, a new tuberculosis drug that has been part of a ground-breaking treatment regimen against […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
Haiti already faced a daunting path to recovery in the wake of the catastrophic 2010 earthquake that destroyed much of its capital city, with devastating damage […]